Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Nausea drug may go over-the-counter

The MHRA has launched a consultation on the reclassification of domperidone 10 mg from a prescription-only medicine to one available over the counter.

The reclassification would make domperidone available for sale in pharmacies for the treatment of nausea and vomiting lasting less than 48 hours.

This comes over and above the existing OTC indications for medicines containing domperidone, for vomiting, dyspepsia and gastro-oesophageal reflux.

The MHRA said the switch would allow individuals to self-manage, as part of an ongoing shift to make more medicine available over the counter at pharmacies, and would cut unnecessary referrals to GPs.

‘Currently there is little choice of treatment available for purchase in pharmacies to manage these situations, leaving pharmacists frequently having to refer patients to their doctors', the consultation document states.

‘Pharmacists know how the symptoms could be managed and are well placed to manage the symptoms of nausea and vomiting of limited duration,' it added.

The consultation will close on 7 May.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say